Relationship of cytokines, oxidative stress and GI motility with bacterial overgrowth in ulcerative colitis patients

Journal of Crohn's and Colitis

Volumn 8, Issue 8, 2014, Pages 859-865

  Rana, Satya Vati ^a   Sharma, Surendra ^a   Kaur, Jaspreet ^a   Prasad, Kaushal Kishore ^a   Sinha, Saroj Kant ^a   Kochhar, Rakesh ^a   Malik, Aastha ^a   Morya, Rajesh Kumar ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cytokines; Orocecal transit time; Oxidative stress; Small intestinal bacterial overgrowth; Ulcerative colitis

Indexed keywords

GLUCOSE; GLUTATHIONE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LACTULOSE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; AGED; ARTICLE; BACTERIAL OVERGROWTH; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL MOTILITY; HUMAN; HYDROGEN BREATH TEST; INTESTINE PARAMETERS; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OROCECAL TRANSIT TIME; OXIDATIVE STRESS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMALL INTESTINAL BACTERIAL OVERGROWTH; ULCERATIVE COLITIS; BLOOD; CASE CONTROL STUDY; COLITIS, ULCERATIVE; GASTROINTESTINAL TRANSIT; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT; FALSE NEGATIVE RESULT; INCIDENCE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ADULT; AGED; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; LIPID PEROXIDATION; MIDDLE AGED; OXIDATIVE STRESS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84900456252     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.01.007     Document Type: Article

References (43)

1. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
2. Takahashi F., Das K.M. Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis. J Clin Invest 1985, 76:311-418.
3. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998, 115:182-205.
4. Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989, 170:2081-2095.
5. Willems F., Marchant A., Delville J.P., Yoshino T., Nishibori M., Tanaka N. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994, 24:1007-1009.
6. De Waal-Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J.E. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991, 174:1209-1220.
7. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991, 147:3815-3822.
8. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39:44-84.
9. Haddad J.J., Harb H.L. L-Gamma-glutamyl-l-cysteinyl-glycine (glutathione; GSH) and GSH related enzymes in the regulation of pro and anti inflammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensor(s)?. Mol Immunol 2005, 42:987-1014.
10. Mizutani T., Akiho H., Khan W.I., Murao H., Ogino H., Kanayama K., et al. Persistent gut motor dysfunction in a murine model of T-cell-induced enteropathy. Neurogastroenterol Motil 2010, 22:196-203.
11. Akiho H., Ihara E., Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol 2010, 1:97-105.
12. Kaur J., Rana S.V., Gupta R. Prolonged orocecal transit time enhances serum bile acids through bacterial overgrowth, contributing factor to gallstone disease. J Clin Gastroenterol June 2013, [Accepted for publication]. 10.1097/MCG.0b013e3182a14fba.
13. Rana S.V., Sinha S.K., Lal S., Sikander A., Singh K. Small intestinal bacterial overgrowth in north Indian patients with celiac disease. Trop Gastroenterol 2007, 28:159-161.
14. Ghoshal U.C., Ghoshal U., Das K., Misra A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian J Gastroenterol 2006, 25:6-10.
15. Rana S.V., Bhansali A., Bhadada S., Sharma S., Kaur J., Singh K. Orocecal transit time and small intestinal bacterial overgrowth in type 2 diabetic patients from North India. Diabetes Technol Ther 2011, 13:1115-1520.
16. Pimentel M., Wallace D., Hallegua D., Chow E., Kong Y., Park S., et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis 2004, 63(4):450-452.
17. Rana S.V., Kocchar R., Pal R., Nagi B., Singh K. Orocecal transit time in patients in chronic phase of corrosive injury. Dig Dis Sci 2008, 53:1797-1800.
18. Pimentel M., Chow E.J., Lin H.C. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000, 95:3503-3506.
19. Rana S.V., Sharma S., Malik A., Kaur J., Prasad K.K., Sinha S.K., et al. Small intestinal bacterial overgrowth and orocecal transit time in patients of inflammatory bowel disease. Dig Dis Sci 2013, 58(9):2594-2598.
20. Ohkawa H., Oshishi N., Yagi K. Reaction of linolenic and hydroperoxide with TBA. J Lipid Res 1978, 19:1053-1057.
21. Ellman G.L. Tissue sulphydryl groups. Arch Biochem Biophys 1959, 82:70-77.
22. Oppenheim J.J., Neta R. Pathophysiological roles of cytokines in development, immunity and inflammation. FASEB J 1994, 8:158-162.
23. Reimund J.M., Wittersheim C., Dumont S., Muller C.D., Baumann R., Poindron P., et al. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J Clin Immunol 1996, 16(3):144-150.
24. Umehara Y., Kudo M., Nakaoka R. Plasma proinflammatory cytokines and adhesion molecules in ulcerative colitis. Hepatogastroenterology 2006, 53(72):879-882.
25. Sands B.E., Kaplan G.G. The role of TNF-alpha in ulcerative colitis. J Clin Pharmacol 2007, 47(8):930-941.
26. Sagynbaeva V.E., Lazebnik L.B., Kniazev O.V., Efremov L.I. Dynamics of proinflammatory cytokine in biological therapy of inflammatory bowel disease. Eksp Klin Gastroenterol 2012, 2:76-87.
27. Avdagic N., Babic N., Seremet M., Delic-Sarac M., Drace Z., Denjalic A., et al. Tumor necrosis factor-alpha serum level in assessment of disease activity in inflammatory bowel diseases. Med Glas (Zenica) 2013, 10(2):211-216.
28. Melgar S., Yeung M.M., Bas A., Forsberg G., Suhr O., Oberg A., et al. Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin Exp Immunol 2003, 134(1):127-137.
29. Kucharzik T., Stoll R., Lügering N., Domschke W. Circulating anti-inflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 1995, 100(3):452-456.
30. Murata Y., Ishiguro Y., Itoh J., Munakata A., Yoshida Y. The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. J Gastroenterol 1995, 30S(8):56-60.
31. Khansari N., Shakiba Y., Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov 2009, 3:73-80.
32. Sturniolo G.C., Mestriner C., Lecis P.E., D'Odorico A., Venturi C., Irato P., et al. Altered plasma and mucosal concentrations of trace elements and antioxidants in active ulcerative colitis. Scand J Gastroenterol 1998, 33:644-649.
33. Halliwell B., Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br J Pharmacol 2004, 142:231-255.
34. Durak I., Yasa M.H., Bektas A., Kaçmaz M., Cimen M.Y., Oztürk H.S. Mucosal antioxidant defense is not impaired in ulcerative colitis. Hepatogastroenterology 2000, 47:1015-1017.
35. Tuzun A., Erdil A., Inal V., Aydin A., Baǧci S., Yeşilova Z., et al. Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem 2002, 35:569-572.
36. Bhaskar L., Ramakrishna B.S., Balasubramanian K.A. Colonic mucosal antioxidant enzymes and lipid peroxide levels in normal subjects and patients with ulcerative colitis. J Gastroenterol Hepatol 1995, 10:140-143.
37. McLennan S.V., Heffernan S., Wright L. Changes in hepatic glutathione metabolism in diabetes. Diabetes 1991, 40:344-348.
38. Cucchiara S., Stronati L., Aloi M. Interactions between intestinal microbiota and innate immune system in pediatric inflammatory bowel disease. J Clin Gastroenterol 2012 Oct, 46(Suppl.):S64-S66.
39. Valdovinos M.A., Camilleri M., Zimmerman B.R. Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc 1993, 68:691-702.
40. Isaacs P.E., Kim Y.S. The contaminated small bowel syndrome. Am J Med 1979, 67:1049-1057.
41. Scarpello J.H., Hague R.V., Cullen D.R., Sladen G.E. The 14C glycocholate test in diabetic diarrhea. Br Med J 1976, 2:673-675.
42. Corazza G.R., Menozzi M.G., Strocchi A. The diagnosis of small bowel bacterial overgrowth. Gastroenterology 1990, 98:302-309.
43. Rana S.V., Sharma S., Kaur J., Sinha S.K., Singh K. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Digestion 2012, 85:243-247.